Macrophage membrane-coated nanoparticles for the treatment of infectious diseases

Biomed Mater. 2024 May 23;19(4). doi: 10.1088/1748-605X/ad4aaa.

Abstract

Infectious diseases severely threaten human health, and traditional treatment techniques face multiple limitations. As an important component of immune cells, macrophages display unique biological properties, such as biocompatibility, immunocompatibility, targeting specificity, and immunoregulatory activity, and play a critical role in protecting the body against infections. The macrophage membrane-coated nanoparticles not only maintain the functions of the inner nanoparticles but also inherit the characteristics of macrophages, making them excellent tools for improving drug delivery and therapeutic implications in infectious diseases (IDs). In this review, we describe the characteristics and functions of macrophage membrane-coated nanoparticles and their advantages and challenges in ID therapy. We first summarize the pathological features of IDs, providing insight into how to fight them. Next, we focus on the classification, characteristics, and preparation of macrophage membrane-coated nanoparticles. Finally, we comprehensively describe the progress of macrophage membrane-coated nanoparticles in combating IDs, including drug delivery, inhibition and killing of pathogens, and immune modulation. At the end of this review, a look forward to the challenges of this aspect is presented.

Keywords: drug delivery; immune modulation; infectious disease; inhibition and killing of pathogens; macrophage membrane.

Publication types

  • Review

MeSH terms

  • Animals
  • Cell Membrane* / metabolism
  • Coated Materials, Biocompatible / chemistry
  • Communicable Diseases* / drug therapy
  • Drug Delivery Systems*
  • Humans
  • Macrophages* / metabolism
  • Nanoparticles* / chemistry

Substances

  • Coated Materials, Biocompatible